These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7630497)

  • 1. Interdependance of the level of the steady potential of the brain and visual evoked potentials in human aging: the norm and Alzheimer's disease.
    Fokin VF; Ponomareva NV
    Neurosci Behav Physiol; 1995; 25(2):136-41. PubMed ID: 7630497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The interrelation of the level of the brain DC potential and visual evoked potentials during human aging: the norm and Alzheimer's disease].
    Fokin VF; Ponomareva NV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1994; 44(2):222-8. PubMed ID: 8023561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroimmune interactions in normal aging and in Alzheimer disease].
    Ponomareva NV; Fokin VF; Androsova LV; Koliaskina GI; Selezneva ND; Gavrilova SI
    Vestn Ross Akad Med Nauk; 1995; (12):27-32. PubMed ID: 8664599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brain evoked potentials in patients with Alzheimer's disease and schizophrenia: a comparative study].
    Chen X; Zhang M; Wang J
    Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):674-6. PubMed ID: 11038791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of Alzheimer's disease, normal aging and scopolamine on human transient visual evoked potentials.
    Smith AT; Early F; Jones GH
    Psychopharmacology (Berl); 1990; 102(4):535-43. PubMed ID: 2096411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of scopolamine on visual evoked potentials in aging and dementia.
    Ray PG; Meador KJ; Loring DW; Murro AM; Buccafusco JJ; Yang XH; Zamrini EY; Thompson WO; Thompson EE
    Electroencephalogr Clin Neurophysiol; 1991; 80(5):347-51. PubMed ID: 1716558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Visual evoked potentials in Alzheimer's and Parkinson disease].
    Zimmer R; Walther H; Kurz A; Haupt M; Lehmann-Horn F; Lauter H
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1991 Dec; 22(4):239-45. PubMed ID: 1786786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation between the changes in evoked and constant potentials of the brain and emotional disorders in Alzheimer's disease].
    Ponomareva NV; Selezneva ND; Voskresenskaia NI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(9):92-7. PubMed ID: 2609833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early visual evoked potentials and mismatch negativity in Alzheimer's disease and mild cognitive impairment.
    Stothart G; Kazanina N; Näätänen R; Haworth J; Tales A
    J Alzheimers Dis; 2015; 44(2):397-408. PubMed ID: 25261446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Specificity of visual evoked potential alterations in Alzheimer's disease].
    Gilles C; de Buyl O; Genevrois C; Salama M; Mendlewicz J
    Neurophysiol Clin; 1991 Dec; 21(5-6):425-37. PubMed ID: 1808501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual evoked potentials in Alzheimer's disease: correlations with age and severity.
    Philpot MP; Amin D; Levy R
    Electroencephalogr Clin Neurophysiol; 1990; 77(5):323-9. PubMed ID: 1697523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of visual evoked potentials and background electroencephalographic activity in young and elderly subjects.
    Goodman C; Rodionov V; Rosenstein GZ; Sohmer H
    J Basic Clin Physiol Pharmacol; 2003; 14(3):265-99. PubMed ID: 14964738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible neurophysiological markers of genetic predisposition to Alzheimer's disease.
    Ponomareva NV; Fokin VF; Selesneva ND; Voskresenskaia NI
    Dement Geriatr Cogn Disord; 1998; 9(5):267-73. PubMed ID: 9701678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of visual evoked potential changes in Alzheimer's disease.
    Coburn KL; Arruda JE; Estes KM; Amoss RT
    J Neuropsychiatry Clin Neurosci; 2003; 15(2):175-9. PubMed ID: 12724458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed late component of visual global field power in probable Alzheimer's disease.
    Coburn KL; Ashford JW; Moreno MA
    J Geriatr Psychiatry Neurol; 1993; 6(2):72-7. PubMed ID: 8512633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual evoked potentials in early Alzheimer's dementia: an exploratory study.
    Grayson AS; Weiler EM; Sandman DE
    J Gen Psychol; 1995 Jan; 122(1):113-29. PubMed ID: 7714499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interhemispheric asymmetry and neuroimmune modulation in normal aging and Alzheimer's-type dementias].
    Fokin VF; Ponomareva NV; Androsova LV; Gavrilova SI
    Fiziol Cheloveka; 1997; 23(3):20-4. PubMed ID: 9264942
    [No Abstract]   [Full Text] [Related]  

  • 18. Visual evoked potentials in dementia: selective delay of flash P2 in probable Alzheimer's disease.
    Coburn KL; Ashford JW; Moreno MA
    J Neuropsychiatry Clin Neurosci; 1991; 3(4):431-5. PubMed ID: 1821266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroencephalogram-based scaling of multifocal visual evoked potentials: effect on intersubject amplitude variability.
    Klistorner AI; Graham SL
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2145-52. PubMed ID: 11481284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased long distance event-related gamma band connectivity in Alzheimer's disease.
    Başar E; Femir B; Emek-Savaş DD; Güntekin B; Yener GG
    Neuroimage Clin; 2017; 14():580-590. PubMed ID: 28367402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.